Remote Cardiac Monitoring by the Corsano CardioWatch 287-2 Evaluation Study

Remote Cardiac Monitoring by the Corsano CardioWatch 287-2 Evaluation Study - RECAMO study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON56059

Enrollment

175

Registered

2022-11-25

Start date

2023-06-15

Completion date

Unknown

Last updated

2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

The Corsano CardioWatch 287-2 will be investigated in this study. The CardioWatch 287-2 is a remote monitoring device intended for continuous and spot measurements collection of physiological data in

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * >= 18 years old; * able to provide consent; * receiving EKG holter or automatic blood pressure cuff for home monitoring per doctor prescription

Exclusion criteria

Exclusion criteria: * unable to wear the Corsano CardioWatch 287 due to reasons such as allergic reactions, wounds, amputations etc.; * unable to receive blood pressure measurements per cuff due to lymphedema, amputation, dyalisis shunt, wounds, etc.; * pregnant women; * breastfeeding women; * upper arm circumference not within the cuff range (22-42 cm) * unable or not willing to sign informed consent; * significant mental or cognitive impairment

Design outcomes

Primary

Measure	Time frame
Absolute percentage increase of patients in whom at least one event of atrial fibrillation is detected by the Corsano CardioWatch 287-2 during 28 days of monitoring, compared to a conventional EKG holter during 24-48 hours of monitoring.	—

Secondary

Measure	Time frame
(1) Mean blood pressure difference and its SD between blood pressure measured by the Corsano CardioWatch 287-2 and blood pressure measured by a conventional oscillometric blood pressure cuff. (2) Usability of the Corsano CardioWatch 287-2 in a remote care setting as determined by a questionnaire. (3) Difference between awake-asleep blood pressure change as measured by the Corsano CardioWatch 287-2 and awake-asleep blood pressure change as measured by a conventional 30-min. oscillometric blood pressure cuff across 24 hours.	—

Measure

Time frame

(1) Mean blood pressure difference and its SD between blood pressure measured by the Corsano CardioWatch 287-2 and blood pressure measured by a conventional oscillometric blood pressure cuff. (2) Usability of the Corsano CardioWatch 287-2 in a remote care setting as determined by a questionnaire. (3) Difference between awake-asleep blood pressure change as measured by the Corsano CardioWatch 287-2 and awake-asleep blood pressure change as measured by a conventional 30-min. oscillometric blood pressure cuff across 24 hours.

—

Countries

Netherlands

Contacts

Public ContactEML Ferraris

Corsano Health B.V.

elena@corsano.com+31 638478134

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Mar 20, 2026